ResBiotic
ResBiotic is developing first-in-class products that aim to alleviate the neutrophilic inflammation associated with dysbiosis to improve respiratory health.
1
Funding Rounds
$3.0m
Money raised
Overview
ResBiotic is developing first-in-class products that aim to alleviate the neutrophilic inflammation associated with dysbiosis to improve respiratory health.
-
Website:
- Business model: B2C
- Social accounts:
Funding series
Funding Series Analysis
The company ResBiotic has raised a total of $3m in funding over 1 rounds.
Key Insights:
- ResBiotic Seed round, April 2021: $3m
ResBiotic Seed round, April 2021
$3m
Industries
ResBiotic is active in the following industries: